Spire’s biomedical R&D initiatives are in the areas of biomaterials and biophotonics life sciences.
|
|
Let Spire R&D develop a customized process and coatings for your unique application. Contact Us
Leveraging its extensive government funded research activities, Spire R&D has established a major biophotonics life science initiative aimed at developing new types of laser-based components and semiconductor-related services for the life sciences instruments market. As a key technology for genomics and optical instruments that characterize DNA and biological agents, biophotonics offers exciting growth opportunities for Spire.
Spire R&D has been awarded a number of US federal contracts in these areas, including a Center for Disease Control (CDC) grant for designing a portable optical instrument for plague detection and a National Institutes of Health (NIH) grant to develop a new fiber laser-based instrument for glaucoma surgery.
Examples of biophotonics instruments that have been, or are currently being developed at Spire R&D include:
|
|
Let Spire R&D develop a custom instrument to give you a competitive edge. Contact Us